Literature DB >> 1442718

The relation of high density lipoprotein cholesterol and its subfractions to apolipoprotein A-I and fasting triglycerides: the role of environmental factors. The Atherosclerosis Risk in Communities (ARIC) Study.

W Patsch1, A R Sharrett, P D Sorlie, C E Davis, S A Brown.   

Abstract

Cross-sectional analysis of four general representative populations of middle-aged adults in the United States in 1986-1989 provides estimates of the close relation of high density lipoprotein cholesterol (HDL cholesterol) to its major structural apolipoprotein (apolipoprotein A-I) and to fasting plasma triglyceride levels. HDL cholesterol differences of approximately 0.4 mg were associated with 1-mg differences in apolipoprotein A-I; differences of 20% in HDL cholesterol (reductions) were associated with triglyceride doublings. Variation in apolipoprotein A-I and triglyceride concentration together accounted for 66% of the population variance in HDL cholesterol. The uniformity of this pattern in the four race-sex groups studied suggests an important role of triglyceride-cholesterol transfer as a determinant of HDL cholesterol. The fundamental relations observed among HDL cholesterol, apolipoprotein A-I, and triglycerides were unaltered by levels of factors under personal volition. The volitional factors appeared to influence HDL cholesterol indirectly: Obesity and physical activity were affected primarily through their associations with triglycerides, and alcohol use and smoking through associations with apolipoprotein A-I. The association of alcohol use with elevated HDL cholesterol was attenuated in persons with greater body mass.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1442718     DOI: 10.1093/oxfordjournals.aje.a116532

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  8 in total

1.  Coronary heart disease risk factors and cigarette smoking among rural African Americans.

Authors:  J P Willems; D E Hunt; J B Schorling
Journal:  J Natl Med Assoc       Date:  1997-01       Impact factor: 1.798

2.  Second-trimester and third-trimester maternal lipid profiles significantly correlated to LGA and macrosomia.

Authors:  Fangfang Xi; Huiqi Chen; Qinqing Chen; Danqing Chen; Yuan Chen; Matthew Sagnelli; Guangdi Chen; Baihui Zhao; Qiong Luo
Journal:  Arch Gynecol Obstet       Date:  2021-03-02       Impact factor: 2.344

3.  Lifestyle changes and 14-year change in high-density lipoprotein cholesterol in a cohort of male physicians.

Authors:  Catherine Rahilly-Tierney; Howard D Sesso; Luc Djoussé; John Michael Gaziano
Journal:  Am Heart J       Date:  2011-04       Impact factor: 4.749

4.  A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol.

Authors:  R Guerra; J Wang; S M Grundy; J C Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

5.  Apolipoprotein E polymorphism influences postprandial retinyl palmitate but not triglyceride concentrations.

Authors:  E Boerwinkle; S Brown; A R Sharrett; G Heiss; W Patsch
Journal:  Am J Hum Genet       Date:  1994-02       Impact factor: 11.025

6.  Relationship of alcohol consumption and type of alcoholic beverage consumed with plasma lipid levels: differences between Whites and African Americans of the ARIC study.

Authors:  Kelly A Volcik; Christie M Ballantyne; Flavio D Fuchs; A Richey Sharrett; Eric Boerwinkle
Journal:  Ann Epidemiol       Date:  2007-09-14       Impact factor: 3.797

7.  Moderate alcohol consumption and lipoprotein subfractions: a systematic review of intervention and observational studies.

Authors:  Trine L Wilkens; Kaare Tranæs; Jane N Eriksen; Lars O Dragsted
Journal:  Nutr Rev       Date:  2022-04-08       Impact factor: 6.846

8.  Maternal lipids associated with large-for-gestational-age birth weight in women with type 1 diabetes: results from a prospective single-center study.

Authors:  Paweł Gutaj; Ewa Wender-Ożegowska; Jacek Brązert
Journal:  Arch Med Sci       Date:  2016-03-16       Impact factor: 3.318

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.